| Date Filed | Type | Description |
| 02/27/2023 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 6,293 options to buy
@ $38.6, valued at
$242.9k
Granted 3,886 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 3,882 shares
@ $0
Disposed/sold 3,882 restricted stock units
@ $0 |
|
| 02/08/2023 |
5
| NEWHALL CHARLES W III (Director) has filed a Form 5 on SUPERNUS PHARMACEUTICALS, INC. |
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2018 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Granted 8,613 options to buy
@ $39.4, valued at
$339.4k
|
|
| 06/15/2017 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Granted 6,036 options to buy
@ $38.6, valued at
$233k
|
|
| 02/27/2017 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC |
| 03/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/07/2015 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Acquired 33,127 shares
@ $0 |
|
| 11/13/2015 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Acquired 33,159 shares
@ $0 |
|
| 07/10/2015 |
4/A
| NEWHALL CHARLES W III (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Acquired 289 shares
@ $0 |
|
| 07/02/2015 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Acquired 289 shares
@ $0 |
|
| 06/17/2015 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Acquired 26,012 shares
@ $0 |
|
| 06/01/2015 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 10,000 options to buy
@ $12.43, valued at
$124.3k
|
|
| 03/05/2015 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $9.13, valued at
$182.6k
|
|
| 09/26/2014 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 17,000 options to buy
@ $8, valued at
$136k
|
|
| 01/23/2014 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Granted 7,457 options to buy
@ $9.24, valued at
$68.9k
|
|
| 02/07/2013 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC|
Txns:
| Granted 8,722 options to buy
@ $7.9, valued at
$68.9k
|
|
| 10/18/2012 |
4
| NEWHALL CHARLES W III (10% Owner) has filed a Form 4 on Workday, Inc.|
Txns:
| Converted 6,963,636 convertible preferred
@ $0
Converted 6,963,636 options to buy
@ $0 |
|
| 10/11/2012 |
3
| NEWHALL CHARLES W III (10% Owner) has filed a Form 3 on Workday, Inc. |
| 09/06/2012 |
4
| NEWHALL CHARLES W III (10% Owner) has filed a Form 4 on FUSION-IO, INC.|
Txns:
| Disposed of 4,500,000 shares
@ $0
Acquired 45,000 shares
@ $0
Disposed of 45,000 shares
@ $0
Acquired 1,066 shares
@ $0 |
|
| 08/14/2012 |
4
| NEWHALL CHARLES W III (10% Owner) has filed a Form 4 on FUSION-IO, INC.|
Txns:
| Sold 2,622 shares
@ $25.8725, valued at
$67.8k
|
|
| 08/02/2012 |
4
| NEWHALL CHARLES W III (10% Owner) has filed a Form 4 on HYPERION THERAPEUTICS INC|
Txns:
| Converted 611,185 shares
@ $0
Converted 898,808 shares
@ $0
Disposed of 51,119 shares
@ $0
Converted 2,043 shares
@ $0
Converted 434,096 shares
@ $0
Converted 180,459 shares
@ $0
Converted 177,481 shares
@ $0
Bought 500,000 shares
@ $10, valued at
$5M
Converted 611,185 preferred shares
@ $0
Converted 898,808 preferred shares
@ $0
Exercised (in-or-at-the-money) 125,291 warrants
@ $4.08, valued at
$511.2k
|
|
| 07/25/2012 |
3
| NEWHALL CHARLES W III (10% Owner) has filed a Form 3 on HYPERION THERAPEUTICS INC |
| 07/03/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/16/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/08/2012 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/08/2012 |
4
| NEWHALL CHARLES W III (10% Owner) has filed a Form 4 on SUPERNUS PHARMACEUTICALS INC |
| 05/01/2012 |
4
| NEWHALL CHARLES W III (10% Owner) has filed a Form 4 on FUSION-IO, INC. |
|